Catalyst Wire Dossier Catalyst Wire Dossier

Org 25935

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Org 25935, covering 2016-12-30 to 2016-12-30. Get the full timeline:

Most recent: Clinical Trial Update: Org 25935 Versus Placebo as Augmentation to Cognitive-behavioral Therapy to Treat Panic Disorder (P05705) [Phase 2]

See pricing